Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials.

[1]  Rongwei Fu,et al.  Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[2]  S. Yusuf,et al.  Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). , 2009, Journal of the American College of Cardiology.

[3]  Leiv Ose,et al.  ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. , 2009, JAMA.

[4]  R. Detrano,et al.  High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis: A Randomized Controlled Trial , 2009, Stroke.

[5]  R. Asmar,et al.  Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study , 2009, Vascular health and risk management.

[6]  A. Keech,et al.  Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.

[7]  J. Fleg,et al.  Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. , 2008, Journal of the American College of Cardiology.

[8]  A. Zwinderman,et al.  Simvastatin with or without ezetimibe in familial hypercholesterolemia. , 2008, The New England journal of medicine.

[9]  M. Cushman,et al.  Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). , 2008, The American journal of cardiology.

[10]  M. Bots,et al.  Targeting the vessel wall in cardiovascular prevention , 2008 .

[11]  F. Schmidt.  Meta-Analysis , 2008 .

[12]  Luni Chen,et al.  Simvastatin with or without ezetimibe in familial hypercholesterolemia. , 2008, The New England journal of medicine.

[13]  P. McCullough,et al.  Lipids, biomarkers, and noninvasive imaging of atherosclerotic disease activity in clinical trials. , 2008, Reviews in cardiovascular medicine.

[14]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[15]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) , 2007 .

[16]  W. Tracz,et al.  Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis. , 2007, Atherosclerosis.

[17]  Diederick E Grobbee,et al.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial , 2007, The Lancet.

[18]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[19]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[20]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. , 2007, Atherosclerosis.

[21]  D. Grobbee,et al.  Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia , 2007 .

[22]  Diederick E Grobbee,et al.  Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. , 2007, JAMA.

[23]  M. Lauer.  Primary prevention of atherosclerotic cardiovascular disease: the high public burden of low individual risk. , 2007, JAMA.

[24]  S. Lee,et al.  Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal–medial thickness in patients with coronary heart disease , 2007, Heart.

[25]  P. Nilsson,et al.  Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study , 2007, Journal of internal medicine.

[26]  Matthias W. Lorenz,et al.  Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis , 2007, Circulation.

[27]  Jonathan J Deeks,et al.  Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.

[28]  C. Roberts,et al.  Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? , 2007, European heart journal.

[29]  S. Haffner,et al.  Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. , 2006, JAMA.

[30]  T. Buchanan,et al.  Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes. , 2006, Diabetes care.

[31]  R. Vasan,et al.  Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.

[32]  J. McNeil,et al.  Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. , 2006, Journal of the American College of Cardiology.

[33]  A. Sutton,et al.  Comparison of two methods to detect publication bias in meta-analysis. , 2006, JAMA.

[34]  A. Smit,et al.  Effects of Fosinopril and Pravastatin on Carotid Intima-Media Thickness in Subjects With Increased Albuminuria , 2005, Stroke.

[35]  S. Anderssen,et al.  Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. , 2005, Atherosclerosis.

[36]  L. V. Van Bortel.  What does intima-media thickness tell us? , 2005, Journal of hypertension.

[37]  Jeannie K. Lee,et al.  Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins , 2004, Circulation.

[38]  G. Mancia,et al.  Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS—A Randomized Double-Blind Trial , 2004, Stroke.

[39]  R. Kawamori,et al.  Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients. , 2004, Endocrine journal.

[40]  H. Putter,et al.  Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. , 2004, Diabetes care.

[41]  H. Markus,et al.  Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness: The Carotid Atherosclerosis Progression Study , 2004, Stroke.

[42]  B. Brenner,et al.  Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.

[43]  Paul Landais,et al.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. , 2004, Journal of clinical epidemiology.

[44]  G. Mancia,et al.  Absolute and relative changes in carotid intima–media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA) , 2004, Journal of hypertension.

[45]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[46]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[47]  O. Ozturk,et al.  Relation Between Coronary Artery Disease, Risk Factors and Intima-Media Thickness of Carotid Artery, Arterial Distensibility, and Stiffness Index , 2003, Angiology.

[48]  J. David Spence,et al.  Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy , 2002, Stroke.

[49]  Allen J. Taylor,et al.  ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness , 2002, Circulation.

[50]  S. Azen,et al.  Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS) , 2002, Circulation.

[51]  S. Störk,et al.  Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. , 2002, Cardiovascular research.

[52]  A. Kitabatake,et al.  Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease. , 2002, Japanese heart journal.

[53]  S. Kashiwagi,et al.  Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). , 2002, Journal of the American College of Cardiology.

[54]  T. Stijnen,et al.  Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands. , 2002, The Netherlands journal of medicine.

[55]  M. Hori,et al.  A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes , 2002, Diabetologia.

[56]  A. Hughes,et al.  Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. , 2001, Clinical science.

[57]  G. Berglund,et al.  Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness: Main Results From the &bgr;-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) , 2001, Circulation.

[58]  M. Trip,et al.  Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.

[59]  I. Olkin,et al.  Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement , 2000, Oncology Research and Treatment.

[60]  J. Lekakis,et al.  Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. , 2000, The American journal of cardiology.

[61]  L. Labree,et al.  Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. , 2000, Atherosclerosis.

[62]  A. Folsom,et al.  Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. , 2000, American journal of epidemiology.

[63]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[64]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[65]  Mark Woodward,et al.  Epidemiology: Study Design and Data Analysis , 1999 .

[66]  G D Lowe,et al.  Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. , 1999, Stroke.

[67]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[68]  S. Sharp,et al.  Explaining heterogeneity in meta-analysis: a comparison of methods. , 1997, Statistics in medicine.

[69]  A. Zanchetti,et al.  The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long‐term randomized treatment with either verapamil or chlorthalidone on carotid intima‐media thickness , 1998, Journal of hypertension.

[70]  J. Deeks.  When can odds ratios mislead? , 1998 .

[71]  A. Zwinderman,et al.  B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). , 1998, Journal of the American College of Cardiology.

[72]  Stephen J. Sharp,et al.  Meta-analysis regression , 1998 .

[73]  B Hillen,et al.  The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[74]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[75]  C. Furberg,et al.  The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) , 1997, JAMA.

[76]  Stephen B. Manuck,et al.  Psychological stress and the progression of carotid artery disease , 1997, Journal of hypertension.

[77]  G. Gallus,et al.  Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. , 1996, The American journal of medicine.

[78]  BjörnFagerberg,et al.  Multiple Risk Intervention in High-Risk Hypertensive Patients , 1996 .

[79]  B. Fagerberg,et al.  Multiple risk intervention in high-risk hypertensive patients. A 3-year ultrasound study of intima-media thickness and plaques in the carotid artery. Risk Intervention Study (RIS) Group. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[80]  A. Keech,et al.  Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. , 1995, Circulation.

[81]  J. Salonen,et al.  Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. , 1995, Circulation.

[82]  C. Furberg,et al.  Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.

[83]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[84]  C D Naylor,et al.  Incorporating variations in the quality of individual randomized trials into meta-analysis. , 1992, Journal of clinical epidemiology.

[85]  C. Furberg,et al.  Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group. , 1989, The American journal of medicine.

[86]  C D Naylor,et al.  Meta-analysis of controlled clinical trials. , 1989, The Journal of rheumatology.

[87]  F. Harrell,et al.  Regression models in clinical studies: determining relationships between predictors and response. , 1988, Journal of the National Cancer Institute.

[88]  Sternby Nh.  Atherosclerosis in a defined population. An autopsy survey in Malmö, Sweden. , 1968 .

[89]  N. Sternby.  Atherosclerosis in a defined population. An autopsy survey in Malmö, Sweden. , 1968, Acta pathologica et microbiologica Scandinavica.

[90]  C. J. Schwartz,et al.  Relationship Between Arterial Disease in Different Sites , 1962 .

[91]  C. J. Schwartz,et al.  Relationship between arterial disease in different sites. A study of the aorta and coronary, carotid, and iliac arteries. , 1962, British medical journal.

[92]  Wei Young,et al.  The quantitation of atherosclerosis: III. The extent of correlation of degrees of atherosclerosis within and between the coronary and cerebral vascular beds☆ , 1960 .